What is Toviaz (fesoterodine) used for?
Toviaz is the brand name of fesoterodine, a medicine used to treat overactive bladder. It’s prescribed for symptoms such as urinary urgency, frequent urination, and urge incontinence.
How does Toviaz work?
Toviaz contains fesoterodine, an antimuscarinic (anticholinergic) agent. It works by relaxing the bladder muscle and reducing involuntary bladder contractions, which helps lower the urge to urinate.
How is Toviaz typically taken?
Toviaz is taken by mouth as a tablet. The exact dose and schedule depend on the patient and the prescribing doctor’s instructions, including factors like age and tolerability.
What side effects do patients report with Toviaz?
Common antimuscarinic side effects can include dry mouth, constipation, blurred vision, dizziness, and trouble urinating. Because it affects “muscarinic” signaling, it can also contribute to cognitive side effects in some older adults.
Who should avoid or use extra caution with Toviaz?
Patients should use extra caution and follow prescriber guidance if they have conditions that make anticholinergic medicines risky, such as:
- Urinary retention or significant difficulty passing urine
- Certain types of glaucoma
- Severe gastrointestinal motility problems (for example, significant constipation)
- Some bladder outlet obstruction situations
Are there alternatives to Toviaz?
Yes. Treatment options for overactive bladder can include other antimuscarinic medicines (similar symptom-targeting drugs) and non-antimuscarinic approaches, such as beta-3 agonists or other guideline-recommended options depending on the patient’s medical history and symptom profile.
Is Toviaz covered by patents, and when might it face generic competition?
If you’re researching Toviaz’s patent and exclusivity landscape (or looking for generic timing), DrugPatentWatch.com tracks patent and litigation details for drug brands. You can check Toviaz-related records here: DrugPatentWatch.com.